Abstract:Gastric adenocarcinoma typically presents with advanced stage when inoperable. Chemotherapy options include non-targeted and toxic agents, leading to poor 5-year patient survival outcomes. Small molecule ONC201/TIC10 (TRAIL-Inducing Compound #10) induces cancer cell death via ClpP-dependent activation of the integrated stress response (ISR) and up-regulation of the TRAIL pathway. We previously found in breast cancer, pancreatic cancer and endometrial cancer that ONC201 primes tumor cells for TRAIL-mediated cell death through ISR-dependent upregulation of ATF4, CHOP and TRAIL death receptor DR5. We investigated the ability of ONC201 to induce apoptosis in gastric adenocarcinoma cells in combination with recombinant human TRAIL (rhTRAIL) or PEGylated trimeric TRAIL (TLY012). AGS (caspase 8-, KRAS-, PIK3CA-mutant, HER2-amplified), SNU-1 (KRAS-, MLH1-mutant, microsatellite unstable), SNU-5 (p53-mutant) and SNU-16 (p53-mutant) gastric adenocarcinoma cells were treated with ONC201 and TRAIL both in cell culture and in vivo. Gastric cancer cells showed synergy following dual therapy with ONC201 and rhTRAIL/TLY012 (combination indices < 0.6 at doses that were non-toxic towards normal fibroblasts). Synergy was observed with increased cells in the sub-G1 phase of the cell cycle with dual ONC201 plus TRAIL therapy. Increased PARP, caspase 8 and caspase 3 cleavage after ONC201 plus TRAIL further documented apoptosis. Increased cell surface expression of DR5 with ONC201 therapy was observed by flow cytometry, and immunoblotting revealed ONC201 upregulation of the ISR, ATF4, and CHOP. We observed downregulation of anti-apoptotic cIAP-1 and XIAP in all cells except AGS, and cFLIP in all cells except SNU-16. We tested the regimen in an organoid model of human gastric cancer, and in murine sub-cutaneous xenografts using AGS and SNU-1 cells. Our results suggest that ONC201 in combination with TRAIL may be an effective and non-toxic option for the treatment of gastric adenocarcinoma by inducing apoptosis via activation of the ISR, increased cell surface expression of DR5 and down-regulation of inhibitors of apoptosis. Our results demonstrate in vivo anti-tumor effects of ONC201 plus TLY012 against gastric cancer that could be further investigated in clinical trials.

Ad5-EMC6 mediates antitumor activity in gastric cancer cells through the mitochondrial apoptosis pathway.

The Adenovirus Vector-mediated Expression of EMC6 Inhibits Migration of Gastric Cancer Cells via Down-regulating the FAK Signaling Pathway

ER Membrane Protein Complex Subunit 6 (EMC6) is a Novel Tumor Suppressor in Gastric Cancer.

Synergism of Rmv-Hu191 with Cisplatin to Treat Gastric Cancer by Acid Sphingomyelinase-Mediated Apoptosis Requiring Integrity of Lipid Raft Microdomains

N6-(2-hydroxyethyl)-Adenosine Induces Apoptosis via ER Stress and Autophagy of Gastric Carcinoma Cells In Vitro and In Vivo

EMC6/TMEM93 suppresses glioblastoma proliferation by modulating autophagy

Astragalus Extract Inhibits Proliferation but Enhances Apoptosis in Gastric Cancer.

Antitumor Efficacy of a Recombinant Adenovirus Encoding Endostatin Combined with an E1B55KD-deficient Adenovirus in Gastric Cancer Cells

CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer.

Adenoviral Delivery Of The Emx2 Gene Suppresses Growth In Human Gastric Cancer

Adenovirus vector-mediated expression of TMEM166 inhibits human cancer cell growth by autophagy and apoptosis in vitro and in vivo.

Anti-tumor Activity of the X-linked Inhibitor of Apoptosis (XIAP) Inhibitor Embelin in Gastric Cancer Cells

Deletion of TMEM268 Inhibits Growth of Gastric Cancer Cells by Downregulating the ITGB4 Signaling Pathway

Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway

Circ_0008035 promotes the progression of gastric cancer via the regulation of miR-1256/CEACAM6 axis

Effect of vascular endothelial growth factor 165 on apoptosis of human gastric carcinoma cells in vitro and its mechanism

CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells.

Microrna-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS Via Regulating CCNE1 and MYC

AdHu5-apoptin induces G2/M arrest and apoptosis in p53-mutated human gastric cancer SGC-7901 cells

2022-RA-260-ESGO UM-6 Induces Autophagy and Apoptosis Via the Hippo-YAP Signaling Pathway in Cervical Cancer

ONC201/TIC10 plus TLY012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor DR5 in gastric adenocarcinoma